Fisher
Clinical Services, Inc. (October 2, 2012)
Cody
Laboratories, Inc. (October 2, 2012)
United
States Pharmacopeial Convention (October 2, 2012)
Chemic Laboratories, Inc. (October 2, 2012)
Morton Grove Pharmaceuticals (October 2, 2012)
Sigma Aldrich Research Biochemicals, Inc. (October 2, 2012)
AMPAC Fine Chemicals,
LLC. (October 2, 2012)
ISP, Inc. (October 2, 2012)
Apertus Pharmaceuticals, LLC. (October 2, 2012)
Established Aggregate Production Quotas for Schedule I and II
Controlled Substances and Established Assessment of Annual Needs for
the List I Chemicals Ephedrine, Pseudoephedrine, and
Phenylpropanolamine for 2013 (October 1, 2012)
Correction: Definitions Relating to Electronic Orders and Prescriptions for Controlled Substances (September 24, 2012)
Rene Casanova, M.D.; Decision and Order (September 19, 2012)
Cleveland J. Enmon, Jr., M.D.; Decision and Order (September 17, 2012)
Henri Wetselaar, M.D.; Decision and Order (September 17, 2012)
T.J. Mcnichol, M.D.; Decision and Order (September 17, 2012)
Final Rule: Consolidation of Seizure and Forfeiture Regulations (September 12, 2012)
Controlled Substances: Final Adjusted Aggregate Production Quotas
for 2012 (September 10, 2012)
Final Adjusted Assessment of Annual Needs for the List I
Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2012 (September 10, 2012)
More |
